Navigation Links
Comprehensive Health Care Reform Should Be National Priority
Date:9/10/2009

WASHINGTON, Sept. 10 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers of America (PhRMA) President & CEO Billy Tauzin issued the following statement after President Obama's address to a joint session of Congress on health care reform:

"We agree with President Obama: every American should have access to high-quality, affordable health care coverage and services. If done in a smart way, health care reform will benefit patients, the economy and the future of America.

"In life, we get precious few opportunities to fundamentally improve the lives of people all across our great nation. This is one of those times, and we commend the President for his vision and willingness to be open to new and different ideas.

"Today, millions of Americans lack insurance coverage or have excessive co-pays that force them to pass on needed medical treatments. This not only has a detrimental effect on patient health, it also impacts job stability and economic growth in America. Yet, saving money is only part of the solution; saving lives is critically important, too.

"That's why we believe any health reform package must foster continued medical progress and innovation in America. If we are going to cure cancer in our lifetime -- as the President has challenged us to do -- we can't be afraid of taking chances. Innovative new medicines and therapies have dramatically increased life expectancy rates in America and around the world, allowing patients everywhere to live healthier, more productive lives.

"Achieving bipartisan, comprehensive health care reform this year should be a national priority. This is our once-in-a-lifetime opportunity to make a real difference. We will continue to be a constructive partner to help meet this goal."

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008.

PhRMA Internet Address: http://www.phrma.org

For information on stories of hope and survival, visit: http://sharingmiracles.com/

For information on how innovative medicines save lives, visit: http://www.innovation.org

For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org

For information on the danger of imported drugs, visit: http://www.buysafedrugs.info

For more information on public health emergencies, visit http://www.rxresponse.org


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Raleigh Comprehensive and Cosmetic Dentistry Announces Addition of New Practice to Raleigh Dentist Family
2. Small businesses would see lower costs, more comprehensive coverage from health reform
3. Cost Effective Solution for Patient Testing: Introducing Comprehensive and Affordable Molecular Diagnosis With Verifiable Accuracy
4. SYNAPT G2s Power, Versatility and Speed Headlines Comprehensive Portfolio of Mass Spectrometers at IMSC
5. New Survey Takes Important Step in Defining Comprehensive Spine Programs
6. Video: School Nurses Tackle Low Parental Awareness of Meningitis Via Comprehensive National Public Education Campaign
7. School Nurses Tackle Low Parental Awareness of Meningitis Via Comprehensive National Public Education Campaign
8. Quantros and CACTUS Software Establish Strategic Alliance to Provide Customers With Comprehensive Provider Performance Monitoring
9. Nicholas Vogelzang, MD, Joins US Oncology Research Network via Comprehensive Cancer Centers of Nevada
10. New Evidence-Based Research Shows that Universal Comprehensive Eye Exams Would Help More Children Succeed in School
11. New Research Suggests Most Are Willing to Make Tradeoffs and Would Embrace Comprehensive Health Care Reform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... giving viewers the lowdown on sciatica in a new episode of "Success Files," ... on current events and innovation and investigates each subject in-depth with passion and ...
(Date:10/13/2017)... ... 2017 , ... “America On The Brink”: the Christian history of the United ... the creation of published author, William Nowers. Captain Nowers and his wife, Millie, ... spent thirty years in the Navy. Following his career as a naval aviator ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest ... its plans to open a flagship location in Covington, LA at 401 N. U.S. ... Go store next to Office Depot in the Holiday Square shopping center. Its location ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) ... FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... Morris F. Collen, a pioneer in the field of medical informatics, this prestigious award ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/25/2017)... 2017   Montrium , an industry leader ... the IQPC Trial Master Files & Inspection Readiness ... EastHORN Clinical Services has selected eTMF Connect ... management. EastHORN, a leading European contract research organization ... transparency to enable greater collaboration with sponsors, improve ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
Breaking Medicine Technology: